Cerus
CERS
#7441
Rank
S$0.55 B
Marketcap
S$2.91
Share price
-2.14%
Change (1 day)
15.86%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -S$9.6 Million

According to Cerus's latest financial reports the company's current earnings are S$0.19 Billion. In 2024 the company made an earning of -S$15.13 Million, an increase over its 2023 earnings that were of -S$36.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$9.6 Million-36.57%
2024 -S$15.13 Million-58.95%
2023 -S$36.84 Million-20.74%
2022 -S$46.47 Million-25.7%
2021 -S$62.54 Million-11.99%
2020 -S$71.06 Million-14%
2019 -S$82.63 Million21.73%
2018 -S$67.88 Million-0.65%
2017 -S$68.33 Million-10.96%
2016 -S$76.74 Million4.24%
2015 -S$73.62 Million50.99%
2014 -S$48.76 Million-10.08%
2013 -S$54.23 Million184.13%
2012 -S$19.09 Million-7.91%
2011 -S$20.73 Million
2009 -S$29.27 Million-24.69%
2008 -S$38.86 Million-25.2%
2007 -S$51.96 Million330.54%
2006 -S$12.07 Million1.49%
2005 -S$11.89 Million-61.02%
2004 -S$30.51 Million
2002 -S$75.46 Million10.02%
2001 -S$68.58 Million34.25%
2000 -S$51.09 Million61.02%
1999 -S$31.73 Million-18.81%
1998 -S$39.08 Million93.08%
1997 -S$20.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.16 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
S$18.6 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
S$0.30 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.08 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA